comparemela.com
Home
Live Updates
New Research from Spherix Finds Increased Use of SGLT2 Inhib
New Research from Spherix Finds Increased Use of SGLT2 Inhib
New Research from Spherix Finds Increased Use of SGLT2 Inhibitors Across the EU5, Including AstraZeneca's Forxiga (Farxiga in US), in the Management of IgA Nephropathy Patients
/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger's...
Related Keywords
Germany ,
Italy ,
Japan ,
United Kingdom ,
France ,
Spain ,
Denise Foy ,
Cemdisiran Alnylam ,
Sparsentan Travere ,
Callidita Kinpeygo ,
Narsoplimab Omeros ,
Ionis Pharmaceuticals ,
Novartis ,
Market Dynamix ,
Iga Nephropathy ,
World Dynamix ,
Vera Therapeutics ,
Realworld Dynamix ,
Global Insights ,
Nephrology Franchise Head ,
Spherix Global Insights ,